Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165412 · ClinicalTrials.gov registry record
Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- 148
- Enrollment target
NCT00165412 is a clinical trial that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 148 participants.
The verdict
NCT00165412 has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.
Interventions
- PROCEDURE Mammogram
- PROCEDURE breast MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2005-07 |
| Est. Completion | 2010-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00165412
The ClinicalTrials.gov registry entry for NCT00165412 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mammogram is the first listed.
NCT00165412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00165412 about?
NCT00165412 is a clinical study titled "Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease". The purpose of this study is to determine if the use of breast MRI in detecting breast malignancies in survivors of Hodgkin's disease is more successful than the traditional mammogram.
What is the current status of trial NCT00165412?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2005-07. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00165412?
The interventions under investigation include: Mammogram (PROCEDURE), breast MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00165412?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.